David A. Jenkins - 12 Feb 2026 Form 4 Insider Report for Catheter Precision, Inc. (VTAK)

Reporting relationship: Chairman of the Board and CEO, Director
Issuer ticker: VTAK
Reported as of: 12 Feb 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 Feb 2026, 16:16:13 UTC
Prior SEC filing: 20 Jan 2026
Next SEC filing: 30 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ David A Jenkins

Key filing fact

David A. Jenkins filed Form 4 for Catheter Precision, Inc. (VTAK) on 18 Feb 2026.

Key facts

This page summarizes David A. Jenkins's Form 4 filing for Catheter Precision, Inc. (VTAK).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 18 Feb 2026, 16:16.

Change

Previous filing in this sequence was filed on 20 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001279803 Primary reporting owner

JENKINS DAVID A

Relationship: Chairman of the Board and CEO, Director
Address: 1670 HIGHWAY 160 WEST, SUITE 205, FORT MILL
Signature: /s/ David A Jenkins
Signature date: 18 Feb 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VTAK transaction Derivative

Series J Preferred Stock

Other

Transaction value
Shares: +2,491
Change %
Price
Shares after: 2,491
Date: 12 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,596,983
Exercise price: $1.56
Footnotes: F1, F2, F3, F4

VTAK transaction Derivative

Series J Preferred Stock

Other

Transaction value
Shares: +6,998
Change %
Price
Shares after: 6,998
Date: 12 Feb 2026
Ownership: See Footnote
Underlying class: Common Stock
Underlying amount: 4,486,022
Exercise price: $1.56
Footnotes: F1, F2, F3, F4, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Series J Exchange Agreement entered into with the Company to cancel accrued royalty amount and terminate royalty right in exchange for Series J Preferred Stock, as more fully described in the Current Report on Form 8-K filed with the Securities and Exchange Commission on February 12, 2026 (the "Form 8-K").

Footnote F2

Series J Preferred Stock is not exercisable until stockholder approval is received, as more fully described in the Form 8-K.

Footnote F3

Series J Preferred Stock has no expiration date.

Footnote F4

The consideration and price paid for the Series J Preferred Stock is more fully described in the Form 8-K.

Footnote F5

Mr. Jenkins is the managing member of SeaCap Management LLC, the general partner of FatBoy Capital LP.